v1
Immunogenicity and efficacy over 12 months following a fourth dose of a bivalent mRNA or protein-based COVID-19 vaccine: A randomised controlled trial in Australia
Identifier:nobleid.org/w1/20260418/84CE05FC
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260418/84CE05FC)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims
Paper Authors